期刊文献+

延长每日血液透析和延长每日血液滤过对原位心脏移植术后急性肾损伤的疗效比较 被引量:4

Comparison of therapeutic effects between extended daily hemodialysis and extended daily hemofiltration for acute kidney injury after orthotopic cardiac transplantation
暂未订购
导出
摘要 目的比较延长每日血液透析(EDD)和延长每日血液滤过(EDHF)治疗原位心脏移植术后急性肾损伤(AKI)的有效性和安全性。方法回顾性分析原位心脏移植术后发生AKI行肾脏替代治疗的20例患者,其中行EDD治疗9例,EDHF治疗11例。所有患者均采用临时深静脉置管作为血液透析通路,应用床旁血透机治疗,血流量为200~250 mL/min。EDD组应用1.4 m2聚醚砜膜透析器,治疗时间≥8 h/d。EDHF组应用1.7 m2高通量聚醚砜膜透析器,置换总量>48 L/d,治疗剂量约为25 mL.kg-1.h-1,治疗时间≥8 h/d。动态随访两组肾脏替代治疗前和开始治疗后24、72 h的血尿素氮、血肌酐、心率、平均动脉压、急性生理功能和慢性健康状况评分系统Ⅱ(APACHEⅡ)评分,并比较两组患者的住院病死率、肾脏替代治疗天数、重症监护病房停留时间及肾脏替代治疗直接费用。结果肾脏替代治疗前,EDD组与EDHF组间年龄、性别、体重、血肌酐、尿素氮、心率、中心静脉压、APACHEⅡ评分等基线资料的差异均无统计学意义(P值均>0.05),但EDD组的平均动脉压为(81.9±7.1)mmHg(1 mmHg=0.133 kPa),显著高于EDHF组的(73.9±9.1)mmHg(P<0.05)。EDD组治疗24 h后的中心静脉压为(16.6±3.1)cmH2O(1 cmH2O=0.098 kPa),显著低于治疗前的(19.6±4.2)cmH2O(P<0.05)。EDHF组治疗24 h后的中心静脉压、APACHEⅡ评分分别为(16.5±3.3)cmH2O、15.5±4.2,均显著低于治疗前的(20.8±5.0)cmH2O和16.9±4.6(P值均<0.05)。治疗72 h后,EDD、EDHF组的中心静脉压分别为(14.7±2.4)、(14.5±3.3)cmH2O,均较同组治疗24 h时显著下降(P值均<0.05),EDHF组治疗72 h时的APACHEⅡ评分为14.1±4.6,亦较同组治疗24 h时显著降低(P<0.05)。此外,两组肾脏替代治疗前、治疗后24、72 h时的血尿素氮、血肌酐水平均保持稳定,两组间差异也均无统计学意义(P值均>0.05)。两组间肾脏替代治疗天数、重症监护病房停留时间、住院期间病死率的差异均无统计学意义(P值均>0.05),但EDD组的肾脏替代治疗直接费用为(9 600±2 700)元,显著低于EDHF组的(15 300±4 800)元(P<0.01)。结论EDD和EDHF治疗原位心脏移植术后非脓毒症相关性AKI的疗效相当,但EDD治疗费用较低。 Objective To investigate the effectiveness and safety of extended daily hemodialysis (EDD) and extended daily hemofiltration (EDHF) in treatment of patients with acute kidney injury after orthotopic cardiac transplantation (OCT). Methods From May 2000 to September 2008, 20 patients with post-OCT acute kidney injury were included in this retrospective study. Nine patients received EDD and 11 received EDHF. Temporary deep venous was used as dialysis pathway in all patients with a bedside hemodialyzer at a blood rate of 200--250 mL/min. EDD group used 1.4 m^2 poly(ether sulfone) and the treatment time was ≥8 h/d. EDHF group used 1.7 m^2 high-throughput poly(ether sulfone), with the total replacement volume being 〉48 L/d and the treatment dose being 25 mL·kg^-1·h^-1 and treatment time being ≥ 8 h/d. Parameters such as urea nitrogen, serum creatinine, heart rate (HR), mean artery pressure (MAP), central venous pressure (OVP), and acute physiology and chronic health evaluation (APACHE) Ⅱ scores were observed before and 24 h and 72 h after treatment. The hospital mortality, length of IOU stay, length of RRT and the direct cost of RRT were compared between groups. Results Before treatment there was no significant difference in the general data between 2 groups except that the MAP of EDHF group was lower than that of EDD group ([81.9±7.1] mmHg vs. [73.9±9.1] mmHg, 1 mmHg= 0. 133 kPa, P〈0. 05). 24 h after treatment, there was no significant difference of urea nitrogen, serum creatinine, HR, MAP, CVP and APACHE Ⅱscores between the two groups; CVP values of both groups were significantly improved compared with those before treatment ([16.6± 3.1] mmH2O vs. [20.8±5.0] cmH2O, 1 cmH2O= 0.098 kPa, P〈0.05); the APACHE Ⅱ scores of EDHF group was significantly improved compared with that before treatment ( 15.5 ± 4.2 vs. 14.7 ± 2.4, P〈0. 05) ; and the urea nitrogen, serum creatinine, HR, and MAP kept stable. 72 h after treatment, the OVP values of both groups were further improved compared with that at 24 h after treatment [14.7±2.4 vs. 16.6±3.1;[14.5±3.3] cmH2O vs. [16.5±3.3] cmH2O, P〈0.05). The APACHE II scores of EDHF group was also further improved compared with those at 24h after treatment ( 14.1± 4.6 vs. 15.5 ± 4.2, P〈0. 05). The urea nitrogen, serum creatinine, HR, and MAP also kept stable. There was no significant difference in hospital mortality, length of ICU stay, length of RRT between the two groups. The direct cost of RRT in EDD group was lower than that of EDHF group ([9 600±2 700] yuan vs. [15 300±4 800] yuan, P〈0. 01). Conclusion Both EDD and EDHF are effective and safe in treatment of patients with non-septic AKI after OHT. EDD costs less than EDHF. (Shanghai Med J, 2009, 32: 221-225)
出处 《上海医学》 CAS CSCD 北大核心 2009年第3期221-225,共5页 Shanghai Medical Journal
基金 上海市医学发展基金重点课题(2003ZD001) 上海市自然科学基金(05ZR14026)资助项目
关键词 延长每日血液透析 延长每日血液滤过 原位心脏移植手术 急性肾损伤 Extended daily hemodialysis Extended daily hemofiltration Orthotopic cardiac transplantation Acute kidney injury
  • 相关文献

参考文献20

  • 1Boyle J M, Moualla S, Arrigain S, et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis, 2006, 48: 787-796.
  • 2Stevens L M, EI-Hamamsy I, Leblanc M, et al. Continuous renal replacement therapy after heart transplantation. Can J Cardiol, 2004, 20: 619-623.
  • 3Ouseph R, Brier M E, Jacobs A A, et al. Continuous venovenous hemofiltration and hemodialysis after orthotopic heart transplantation. Am J Kidney Dis, 1998, 32: 290-294.
  • 4Marshall M R, Golper T A, Shaver M J, et al. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int, 2001, 60:777-785.
  • 5Kumar V A, Craig M, Depner T A, et al. Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis, 2000, 36 : 294-300.
  • 6王春生.中国大陆心脏移植的现状与进展[J].继续医学教育,2007,21(11):6-9. 被引量:12
  • 7Bone R C, Balk R A, Cerra F B, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101: 1644-1655.
  • 8Beltomo R, Ronco C, Kellum J A, et al. Acute renal failuredefinition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care, 2004, 8: R204-R212.
  • 9陈昊,王春生,赖颢,宋凯,洪涛,姜桢.原位心脏移植术后肾功能损害的防治[J].上海医学,2002,25(9):569-571. 被引量:3
  • 10Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis, 2002, 40: 875-885.

二级参考文献30

  • 1陈子道 夏求明.心脏移植术后肾功能衰竭.现代心脏移植,第1版[M].北京:人民卫生出版社,1998.200-205.
  • 2缪中良 石美鑫.急性肾功能衰竭.实用外科学[M].北京:人民卫生出版社,1992.155,161.
  • 3Marshell MR, Gopler TA, Shaver MJ, et al. Hybrid renal replacement modalities for the critically ill. Contrib Nephrol,2001,132: 252-257.
  • 4Casino FG, Marshall MR. Simple and accurate quantification of dialysis in acute renal failure patients during either urea non-steady state or treatment with irregular or continuous schedules. Nephrol Dial Transplant, 2004, 19:1454-1466.
  • 5Tang HL, Tsang WK, Yueng S, et al. Solute removal index correlates more with equilibrated Kt/V than with single pool Kt/V in haemodialysis patients. Nephrology, 2004,9: 39-43.
  • 6Marshall MR, Ma TM, Galler D, et al. Sustained low-efficiency daily diafiltration(SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequete therapy.Nephrol Dial Transplant, 2004,19:877-884.
  • 7Vanholder R, Biesen WV, Lameire N. What is the renal replacement method of first choice for intensive care patients? J Am Soc Nephrol,2001,12:S40-S43.
  • 8Paramesh AS, Roayaie S, Doan Y, et al. Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease[ J]. Clin Transplant,2004,18( 1 ) :94 -99.
  • 9Thomas G, Kelly D, Norris S, et al. Acute renal failure in orthotopic liver transplantation [ J]. Ir J Med Sci, 1996,165 (4) :271 - 273.
  • 10Uehlinger DE,Jakob SM, Ferrari P, et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure [ J ]. Nephrol Dial Transplant, 2005,20 (8) : 1630 - 1637.

共引文献44

同被引文献75

  • 1李洪,曾丽花,卢飞杏,吴洪兰,陈业珍,李德英,苏庆玲,赵英,黄烈诚.持续缓慢低效血液透析和连续静脉静脉血液滤过的对照研究[J].中华肾脏病杂志,2005,21(6):364-366. 被引量:26
  • 2滕杰,陈利明,邹建洲,方艺,钟一红,吉俊,章晓燕,傅辰生,丁小强.高容量血液滤过治疗置换液配方初探[J].中国血液净化,2005,4(8):447-450. 被引量:9
  • 3Haase M,Shaw A. Acute kidney injury and cardiopulmonary bypass: special situation or same old problem? Contrib Nephrol, 2010,165 : 33-38.
  • 4Fang Y, Ding X, Zhong Y, et al. Acute kidney injury in a Chinese hospitalized population. Blood Purif, 2010, 30: 120- 126.
  • 5Rosner MH,Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol,2006,1119-32.
  • 6Mehta RL. Continuous renal replacement therapy in the critically ill patient. Kidney Int, 2005,67 : 781-795.
  • 7Mehta RL, Kellum JA,Shah SV, et al. Acute Kidney Injury Network : report of an initiative to improve outcomes in acute kidney injury. Crit Care, 2007,11 : R31.
  • 8Bone RC,Balk RA,Cerra FB,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992,101 : 1644-1655.
  • 9Palevsky PM,Zhang JH,OrConnor TZ,et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med,2008,359:7-20.
  • 10Vidal S,Richebe P,Barandon L, et al. Evaluation of continuous veno-venous hemofiltration for the treatment of cardiogenic shock in conjunction with acute renal failure after cardiac surgery. Eur J Cardiothorac Surg, 2009,36 : 572-579.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部